X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Cancer Diagnostics Companies (2024 - 2029)

Numerous companies in the healthcare sector are making significant strides in the field of diagnostics and genetic testing. These firms are investing in advanced technologies and research to enhance their offerings and provide more accurate and efficient diagnostic solutions. They are also collaborating with other entities to create innovative products and improve patient outcomes. These companies are playing a crucial role in the detection and treatment of various diseases, including cancer. Their efforts are contributing to advancements in personalized medicine and are shaping the future of healthcare.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Oncology Diagnostics Research Cancer Diagnostics Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Cancer Diagnostics Market

This report lists the top Cancer Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Cancer Diagnostics industry.

  1. Roche

  2. Thermo Fisher Scientific

  3. Abbott Laboratories

  4. Illumina

  5. bioMérieux

*Disclaimer: Top companies sorted in no particular order

Cancer Diagnostics Market Major Players

Cancer Diagnostics Market Concentration

Cancer Diagnostics Market Concentration

Cancer Diagnostics Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Government Initiatives

      2. 4.2.2 Increasing Burden of Cancer Globally

      3. 4.2.3 Emergence of New Technologies Such as Biomarkers and Point of Care Testing

    3. 4.3 Market Restraints

      1. 4.3.1 Limited Use in the Emerging Markets

      2. 4.3.2 Expensive Diagnostic Procedures

    4. 4.4 Porters Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Diagnostic Type

      1. 5.1.1 Diagnostic Imaging Tests

      2. 5.1.2 Biopsy and Cytology Tests

      3. 5.1.3 Tumor Biomarkers

      4. 5.1.4 Other Diagnostic Types

    2. 5.2 By Application

      1. 5.2.1 Breast Cancer

      2. 5.2.2 Lung Cancer

      3. 5.2.3 Cervical Cancer

      4. 5.2.4 Kidney Cancer

      5. 5.2.5 Liver Cancer

      6. 5.2.6 Pancreatic Cancer

      7. 5.2.7 Ovarian Cancer

      8. 5.2.8 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories Inc.

      2. 6.1.2 F. Hoffmann-La Roche Ltd

      3. 6.1.3 Siemens Healthineers

      4. 6.1.4 Thermo Fisher Scientific Inc.

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Hologic Inc.

      7. 6.1.7 Illumina Inc.

      8. 6.1.8 Bio-Rad Laboratories Inc.

      9. 6.1.9 Agilent Technologies Inc.

      10. 6.1.10 Biomeriuex SA

      11. 6.1.11 Cancer Diagnostic Inc.

      12. 6.1.12 Myriad Genetic Laboratories Inc.

      13. 6.1.13 Qiagen

      14. 6.1.14 Agilent Technologies, Inc.

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Cancer Diagnostics Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Cancer Diagnostics Market Companies Summary

The cancer diagnostics sector is highly competitive, with a significant number of both local and international firms operating within the market. These enterprises are employing various strategies to strengthen their market position, including entering into partnerships and agreements, launching new products, expanding geographically, and engaging in mergers and acquisitions. Prominent players in the cancer diagnostics industry include global healthcare companies specializing in various areas such as diagnostics, pharmaceuticals, and biotechnology. These companies are investing in research and development to advance cancer diagnostic technologies, including biomarkers and point-of-care diagnostics. They are also working on developing new imaging devices for cancer diagnosis, contributing to the growth of the diagnostic imaging tests segment in the market.

Explore More

Cancer Diagnostics Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Abbott Laboratories Inc.

      2. 1.1.2 F. Hoffmann-La Roche Ltd

      3. 1.1.3 Siemens Healthineers

      4. 1.1.4 Thermo Fisher Scientific Inc.

      5. 1.1.5 GE Healthcare

      6. 1.1.6 Hologic Inc.

      7. 1.1.7 Illumina Inc.

      8. 1.1.8 Bio-Rad Laboratories Inc.

      9. 1.1.9 Agilent Technologies Inc.

      10. 1.1.10 Biomeriuex SA

      11. 1.1.11 Cancer Diagnostic Inc.

      12. 1.1.12 Myriad Genetic Laboratories Inc.

      13. 1.1.13 Qiagen

      14. 1.1.14 Agilent Technologies, Inc.

    2. *List Not Exhaustive

Cancer Diagnostics Companies FAQs

F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Illumina Inc and bioMérieux SA are the major companies operating in the Cancer Diagnostics Market.

Cancer Diagnostics Market Report Snapshots

Cancer Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)